Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(5R,5aR,8aS,9S)-5-(4-hydroxy-3,5-dimethoxyphenyl)-9-(1H-pyrrolo[2,3-b]pyridin-6-ylamino)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one | - |
Homo sapiens | |
(5R,5aR,8aS,9S)-5-(4-hydroxy-3,5-dimethoxyphenyl)-9-(4H-1,2,4-triazol-3-ylamino)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one | - |
Homo sapiens | |
(5R,5aR,8aS,9S)-5-(4-hydroxy-3,5-dimethoxyphenyl)-9-(9H-purin-6-ylamino)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one | - |
Homo sapiens | |
(5R,5aR,8aS,9S)-5-(4-hydroxy-3,5-dimethoxyphenyl)-9-(imidazo[1,2-a]pyridin-8-ylamino)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one | - |
Homo sapiens | |
(5R,5aR,8aS,9S)-5-(4-hydroxy-3,5-dimethoxyphenyl)-9-{[3-(methylamino)pyridin-2-yl]amino}-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one | - |
Homo sapiens | |
(5R,5aR,8aS,9S)-5-(4-hydroxy-3,5-dimethoxyphenyl)-9-{[3-(piperidin-1-ylmethyl)phenyl]amino}-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one | molecular docking to MDR protein | Homo sapiens | |
(5R,5aR,8aS,9S)-5-(4-hydroxy-3,5-dimethoxyphenyl)-9-{[3-(pyrrolidin-1-ylmethyl)phenyl]amino}-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one | - |
Homo sapiens | |
(5R,5aR,8aS,9S)-5-(4-hydroxy-3,5-dimethoxyphenyl)-9-{[4-(piperidin-1-ylmethyl)phenyl]amino}-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one | - |
Homo sapiens | |
(5R,5aR,8aS,9S)-5-(4-hydroxy-3,5-dimethoxyphenyl)-9-{[4-(pyrrolidin-1-ylmethyl)phenyl]amino}-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one | - |
Homo sapiens | |
(5R,5aR,8aS,9S)-9-({3-[(diethylamino)methyl]phenyl}amino)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one | - |
Homo sapiens | |
(5R,5aR,8aS,9S)-9-({4-[(diethylamino)methyl]phenyl}amino)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one | - |
Homo sapiens | |
(5R,5aR,8aS,9S)-9-[(5,6-diphenyl-1,2,4-triazin-3-yl)amino]-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one | - |
Homo sapiens | |
(5R,5aR,8aS,9S)-9-[(6-aminopyridin-2-yl)amino]-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one | - |
Homo sapiens | |
etoposide | - |
Homo sapiens | |
additional information | design, synthesis, and inhibitory potencies of 4beta-anilino-podophyllotoxin analogues, derived from etoposide, overview. The compounds stabilize the covalent TopoII-DNA cleavage complex by inhibiting the TopoII-mediated religation reaction, in vitro antiproliferation activities against three drug-resistance tumor cell lines | Homo sapiens | |
podophyllotoxin | - |
Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
nucleus | - |
Homo sapiens | 5634 | - |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
A-549 cell | - |
Homo sapiens | - |
K-562 cell | - |
Homo sapiens | - |
U-251 cell | - |
Homo sapiens | - |
U-251 MG cell | - |
Homo sapiens | - |
Synonyms | Comment | Organism |
---|---|---|
DNA-topoisomerase II | - |
Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
additional information | - |
in vitro antiproliferation activities against three drug-resistance tumor cell lines of 4beta-anilino-podophyllotoxin analogues, IC50 values | Homo sapiens | additional information |